Rasalect 1mg (Rasagiline) 1mg

Rasalect 1mg contains rasagiline, a medication used to treat symptoms of Parkinson’s disease. It belongs to the class of MAO-B inhibitors, supporting motor function and daily activity management. Ideal for those seeking reliable symptom control with a trusted active ingredient.

Strength

1mg

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rasalect 1mg is primarily used to manage symptoms of Parkinson’s disease, including tremors, stiffness, and slow movement. It helps improve motor function and daily activities by increasing dopamine levels in the brain. This medication is often prescribed alongside levodopa for enhanced effectiveness in symptom control.

Side Effects

Rasalect 1mg works by slowing the breakdown of dopamine in the brain, which can help reduce symptoms like shaking, rigidity, and difficulty walking. Users may notice improved movement and coordination over time. Effects vary by individual and may take several weeks to become noticeable.

Precautions & Warnings

Store Rasalect 1mg at room temperature, away from moisture and heat. Keep it out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a healthcare provider. Report any unusual side effects, such as severe headache or dizziness, to a medical professional promptly.

Avoid Interactions

Rasalect 1mg may interact with certain antidepressants, opioids, or other MAO inhibitors, increasing the risk of serious side effects. Avoid consuming foods high in tyramine, such as aged cheeses or cured meats, as they can cause dangerous blood pressure spikes. Always inform your doctor about all medications and supplements you are taking.

Frequently Asked Questions

Rasalect 1mg is used to treat symptoms of Parkinson’s disease, such as tremors, stiffness, and slow movement.

Effects may take several weeks to become noticeable as the medication gradually increases dopamine levels in the brain.

Rasalect 1mg is often prescribed alongside levodopa, but always consult your doctor before combining medications.

Avoid foods high in tyramine, such as aged cheeses or cured meats, and consult your doctor about other medication interactions.

Rasalect 1mg is generally safe for long-term use under medical supervision, but regular check-ups are recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.